New detailed skin imaging for skin cancer screening
Part of Cancer, Skin clinical trials.
This study is testing a new, very detailed skin imaging method (super-high magnification dermoscopy) to see if it helps doctors diagnose skin tumors more accurately during routine mole checks. If you are already coming for a skin screening, this might help improve how skin cancers are found.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are coming for a skin cancer screening exam.
- You are willing to take part in the study.
- You can understand and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at images of a type of skin cancer called squamous cell carcinoma to see if certain features in the images can help predict how deep the cancer has grown. This might help doctors plan treatment without needing extra tests.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This trial uses advanced imaging to take detailed pictures of your skin. It may help doctors better understand and diagnose skin conditions.
This trial uses a special optical imaging scan to help diagnose skin cancer without needing a biopsy. It may be a good option if you have a suspicious skin lesion.
This study tests a new device called LumAssure that scans skin to help doctors look at skin conditions. It aims to see if the device works well for people with different skin issues.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
Hear when a new Skin Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.